Labeling error prompts Ohio to stop sales of medical marijuana concentrate

Women, minority execs show few gains in U.S. cannabis industry, according to the latest data from the MJBiz Diversity, Inclusion and Equity Report. Get your copy here.

A labeling error involving medical marijuana concentrate spurred Ohio regulators to halt sales of the product at 13 of 15 retail shops.

It’s believed to be the first time Ohio officials have stopped sales of a product since the Buckeye State’s MMJ program kicked off in January, The (Cincinnati) Enquirer reported.

The targeted product – which was not officially recalled – involved a 1-milliliter syringe of marijuana concentrate made by Grow Ohio.

To read more about why regulators stopped the product sales, click here.